PMID: 7520721Apr 1, 1994Paper

Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization

AIDS Research and Human Retroviruses
A BuchacherA Jungbauer

Abstract

Electrofusion and EBV transformation were studied by immortalizing human PBLs from blood of HIV-1-positive volunteers. A panel of 33 cell lines producing human monoclonal antibodies (Hu-MAbs) against HIV-1 was established by cell fusion or EBV transformation. For the first fusion experiments the source of B lymphocytes was peripheral blood of HIV-1-infected donors in CDC stages II or III with CD4 cell counts higher than 500/mm3. Later on, from these patients only, those with high anti-HIV titers were chosen as blood donors. By that means the yield of stable specific hybridomas was increased twofold. In our experiments electrofusion turned out to be a more efficient immortalization method than EBV transformation, due to a high and constant immortalization rate. The hybridomas were stable after intensive subcloning and could be cultivated over a period of 8 months without loss in monoclonal antibody production. Immunoglobulin class, subtype, reactivity against HIV-1 proteins, Western blot patterns, immunofluorescence, and epitopes were characterized. The subtype of all antibodies was IgG1 or IgG3. The light chain was predominantly kappa. All antibodies showed reactivity against HIV-1 envelope or core protein. All hybridomas were ...Continue Reading

References

Jan 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·P A BrolidenK Broliden
Jun 1, 1992·AIDS Research and Human Retroviruses·S KarwowskaS Zolla-Pazner
Apr 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·M K GornyS Zolla-Pazner
Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A KarpasJ E Epstein
May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J R RuscheP J Fischinger
May 11, 1989·The New England Journal of Medicine·S Zolla-PaznerA Pinter
Sep 30, 1988·Biochemical and Biophysical Research Communications·T SuganoE M Hersh
Mar 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M K GornyS Zolla-Pazner
Jan 1, 1988·Hormone Research·S RöjdmarkG Kallner
Jun 26, 1987·Journal of Immunological Methods·K James, G T Bell
Sep 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·L Olsson, H S Kaplan

❮ Previous
Next ❯

Citations

Feb 1, 2006·Applied Microbiology and Biotechnology·S A JeffsH Holmes
Sep 24, 2008·Applied Microbiology and Biotechnology·Hannes ReisingerRenate Kunert
Jun 14, 2005·Immunology Letters·Xiao-Nan DongYing-Hua Chen
Oct 20, 2001·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·R M RuprechtH M McClure
Dec 11, 2007·Nature Biotechnology·Wayne A Marasco, Jianhua Sui
Oct 29, 2010·Nature Communications·Kuan-Hsiang G HuangPaul Klenerman
Jan 20, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jian YanDavid B Weiner
Mar 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Sheng-Kai WangChi-Huey Wong
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Erin M SchererDennis R Burton
Jul 30, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jennifer R KeeffeStephen L Mayo
Jan 6, 2012·Proceedings of the National Academy of Sciences of the United States of America·Hugo MouquetMichel C Nussenzweig
Jun 30, 2012·Proceedings of the National Academy of Sciences of the United States of America·Anthony P WestPamela J Bjorkman
Apr 20, 2010·The Journal of Biological Chemistry·Willie W L KohRobin A Weiss
Oct 7, 2011·The Journal of Biological Chemistry·Chan-Sien LayPantelis Poumbourios
May 4, 2005·The Journal of Experimental Medicine·Julie M DeckerGeorge M Shaw
Mar 2, 2011·The Journal of Experimental Medicine·Claudia R RuprechtAlexandra Trkola
May 30, 2012·The Journal of Experimental Medicine·Laura E McCoyRobin A Weiss
Jan 30, 2013·The Journal of Experimental Medicine·Guang YangGarnett Kelsoe
Dec 14, 2004·AIDS Research and Human Retroviruses·Kelly R YoungTed M Ross
Dec 1, 1994·AIDS Research and Human Retroviruses·M PurtscherA Jungbauer
Jun 1, 1995·AIDS Research and Human Retroviruses·A R NeurathS Jiang
May 20, 1996·AIDS Research and Human Retroviruses·S CalarotaB Wahren
May 1, 1997·AIDS Research and Human Retroviruses·F Barré-SinoussiM Girard
Oct 28, 2006·AIDS Research and Human Retroviruses·Silvia Sánchez-MartínezJosé L Nieva
Jan 11, 2008·AIDS Research and Human Retroviruses·Lianxing LiuYiming Shao
Feb 21, 2008·AIDS Research and Human Retroviruses·Suganya SelvarajahDennis R Burton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.